Tuesday, May 24, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | World | Bharat Biotechs Partner Seeks Covaxin Approval In Us For Children Below 18 Years

Bharat Biotech’s partner seeks Covaxin approval in US for children below 18 years

By ANI
Published: Updated On - 11:20 AM, Sat - 6 November 21
"We are pleased to announce our EUA filing to the US-Food and Drug Administration (FDA) through our partners- Ocugen," tweeted Dr Raches Ella, Bharat Biotech's clinical lead for Covid-19 vaccines.

New Delhi: Bharat Biotech’s US partner Ocugen has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18.

“We are pleased to announce our EUA filing to the US-Food and Drug Administration (FDA) through our partners- Ocugen,” tweeted Dr Raches Ella, Bharat Biotech’s clinical lead for Covid-19 vaccines.

The World Health Organisation (WHO) on Wednesday granted approval for Emergency Use Listing (EUL) for Bharat Biotech’s COVID-19 vaccine, Covaxin.

The approval was done on the recommendation of the Technical Advisory Group (TAG) for Emergency Use Listing (TAG-EUL), an independent advisory panel that provides recommendations to WHO on whether a COVID-19 vaccine can be listed for emergency use under the EUL procedure.

Bharat Biotech’s Covaxin and AstraZeneca and Serum Institute’s Covishield are the two widely used vaccines in India.

  • Follow Us :
  • Tags
  • Bharat Biotech’s Covaxin
  • Covaxin

Related News

  • Covaxin receives emergency use approval in children aged between 6 and 12

  • Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-olds

  • Ocugen to commercialise Covaxin in Mexico

  • Covaxin, Covishield to cost Rs 225 per dose

  • Bharat Biotech announces slowing down of Covaxin production

  • Bharat Biotech: A journey of 2 suitcases and 40 feet container

Latest News

  • Opinion: The new cold war will be fiercer

    2 hours ago
  • Editorial: Opening doors for regional cooperation

    2 hours ago
  • Cyber fraudsters swindle Rs 2.7 crore using ‘investment bait’ in Cyberabad

    3 hours ago
  • IPL 2022: Gujarat Titans qualify for final with seven-wicket win over RR

    3 hours ago
  • Nutreat offers healthy, nutritious food using traditional techniques

    3 hours ago
  • Q&A session on steps to achieve success amid competition in TT, NT’s awareness programme

    3 hours ago
  • Telangana’s Lavanya makes it to Indian team for U-20 Asian Volleyball Championship

    3 hours ago
  • Think positive, improve skills experts tell aspirants in TT, NT’s awareness programme

    3 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam